Infectious Disease Therapy

Patents awarded in U.S., Australia for multivalent antibody therapy

Published in AIDS Weekly, November 11th, 2002

Immunomedics, Inc., (IMMU) announced the issuance of U.S. Patent No. 6,458,933, which corresponds to Australia patent 742,626 issued May 2, 2002, covering new therapy agents for treating infectious diseases.

According to Dr. Hans J. Hansen, Immunomedics, who invented this new technology, "This patent covers multivalent antibodies that cross-link microorganisms and viruses to monocytes and macrophages - cells that can ingest and destroy the microorganisms. These cells, as well as dendritic cells that are also targeted, can process antigens from the microorganisms and 'educate' immune cells of patients so that they can expand in number and more effectively kill the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-11-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry